HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul J van Diest Selected Research

Male Breast Neoplasms (Male Breast Cancer)

1/2020Methylation Profile of X-Chromosome-Related Genes in Male Breast Cancer.
12/2018PD-1 and PD-L1 Expression in Male Breast Cancer in Comparison with Female Breast Cancer.
1/2017Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
12/2015Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancer.
1/2015Expression of connective tissue growth factor in male breast cancer: clinicopathologic correlations and prognostic value.
11/2013Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification.
1/2013Differential expression of growth factor receptors and membrane-bound tumor markers for imaging in male and female breast cancer.
12/2012Immunophenotyping of male breast cancer.
10/2012Fibrotic focus and hypoxia in male breast cancer.
8/2012Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul J van Diest Research Topics

Disease

162Neoplasms (Cancer)
03/2022 - 01/2002
144Breast Neoplasms (Breast Cancer)
06/2022 - 01/2002
31Neoplasm Metastasis (Metastasis)
01/2021 - 03/2003
28Hypoxia (Hypoxemia)
04/2020 - 01/2002
20Noninfiltrating Intraductal Carcinoma (DCIS)
01/2021 - 11/2003
18Carcinogenesis
01/2022 - 11/2002
13Carcinoma (Carcinomatosis)
01/2018 - 07/2003
12Male Breast Neoplasms (Male Breast Cancer)
01/2020 - 03/2012
9Prostatic Neoplasms (Prostate Cancer)
10/2021 - 02/2007
7Neoplasm Micrometastasis
06/2010 - 11/2004
6Lymphatic Metastasis
01/2022 - 06/2009
6Necrosis
04/2020 - 07/2005
6Ovarian Neoplasms (Ovarian Cancer)
12/2019 - 01/2002
6Squamous Cell Carcinoma of Head and Neck
01/2018 - 06/2009
4Triple Negative Breast Neoplasms
01/2022 - 03/2017
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2014 - 05/2008
4Endometrial Neoplasms (Endometrial Cancer)
09/2010 - 11/2003
3Melanoma (Melanoma, Malignant)
01/2021 - 11/2004
3Colorectal Neoplasms (Colorectal Cancer)
10/2018 - 01/2008
3Adenocarcinoma
12/2017 - 12/2010
2Lobular Carcinoma
10/2018 - 08/2011
2Colonic Neoplasms (Colon Cancer)
01/2017 - 01/2016
2Head and Neck Neoplasms (Head and Neck Cancer)
10/2016 - 02/2016

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2002
32Biomarkers (Surrogate Marker)IBA
06/2022 - 12/2006
21Estrogen ReceptorsIBA
01/2022 - 11/2002
20DNA (Deoxyribonucleic Acid)IBA
10/2019 - 09/2002
16Progesterone Receptors (Progesterone Receptor)IBA
01/2018 - 11/2002
14ParaffinIBA
01/2022 - 12/2003
13Transcription Factors (Transcription Factor)IBA
12/2012 - 03/2003
12Cadherins (E-Cadherin)IBA
06/2022 - 01/2009
12Hormones (Hormone)IBA
06/2019 - 01/2012
10Phenobarbital (Luminal)FDA Link
10/2020 - 03/2012
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2017 - 01/2002
10ErbB Receptors (EGF Receptor)IBA
10/2016 - 11/2002
9Formaldehyde (Formol)FDA Link
01/2022 - 05/2008
9human ERBB2 proteinIBA
02/2021 - 01/2010
9Trastuzumab (Herceptin)FDA Link
02/2021 - 01/2009
8Carbonic Anhydrase IXIBA
04/2020 - 01/2005
8Biological ProductsIBA
01/2017 - 01/2002
8Cyclin D1IBA
12/2012 - 12/2003
7Messenger RNA (mRNA)IBA
10/2021 - 12/2008
7RNA Helicases (RNA Helicase)IBA
10/2021 - 01/2013
7Estrogen Receptor alphaIBA
02/2021 - 01/2010
6Hematoxylin (Haematoxylon)IBA
12/2017 - 03/2003
5MicroRNAs (MicroRNA)IBA
12/2021 - 10/2015
5Eosine Yellowish-(YS) (Eosin)IBA
12/2017 - 04/2011
5Oxygen (Dioxygen)IBA
12/2012 - 12/2005
5Cyclin AIBA
08/2007 - 11/2002
4AntigensIBA
01/2022 - 11/2004
4TamoxifenFDA LinkGeneric
11/2021 - 01/2014
4Single-Domain AntibodiesIBA
10/2020 - 04/2006
4Glucose (Dextrose)FDA LinkGeneric
04/2020 - 01/2002
4Androgen Receptors (Androgen Receptor)IBA
01/2020 - 05/2012
4AntibodiesIBA
01/2018 - 11/2002
4ChromatinIBA
01/2018 - 01/2005
4Cisplatin (Platino)FDA LinkGeneric
09/2017 - 02/2004
4Membrane Proteins (Integral Membrane Proteins)IBA
11/2014 - 06/2012
4Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
06/2012 - 12/2006
3RNA (Ribonucleic Acid)IBA
01/2022 - 12/2016
31-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2020 - 10/2016
3Pharmaceutical PreparationsIBA
01/2019 - 11/2014
3Hypoxia-Inducible Factor 1IBA
02/2015 - 01/2005
3Growth Factor ReceptorsIBA
08/2013 - 11/2002
3Indicators and Reagents (Reagents)IBA
04/2008 - 04/2007
3Fanconi Anemia Complementation Group D2 ProteinIBA
01/2008 - 10/2003
3Cell Cycle ProteinsIBA
08/2007 - 01/2004
24-azidobenzylcarazolol (pABC)IBA
01/2022 - 12/2021
2Aromatase InhibitorsIBA
11/2021 - 01/2012
2Estrogens (Estrogen)FDA Link
01/2020 - 04/2004
2CateninsIBA
01/2019 - 01/2018
2PlatinumIBA
01/2019 - 01/2005
2somatostatin receptor 2IBA
12/2018 - 01/2017
2AntioxidantsIBA
10/2018 - 07/2005
2Histones (Histone)IBA
10/2018 - 09/2012
2Protons (Proton)IBA
01/2018 - 02/2012
2SteroidsIBA
01/2018 - 08/2017
2Ribonucleases (Ribonuclease)IBA
06/2017 - 01/2013
2Fluorescent Dyes (Fluorescent Probes)IBA
01/2017 - 07/2013
2Histone Deacetylases (Histone Deacetylase)IBA
04/2016 - 10/2013
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
02/2016 - 01/2016
2TNF Receptor-Associated Factor 4IBA
03/2014 - 08/2012
2Insulin (Novolin)FDA Link
11/2013 - 06/2012

Therapy/Procedure

51Therapeutics
01/2022 - 07/2003
24Ligation
01/2019 - 01/2009
12Drug Therapy (Chemotherapy)
11/2021 - 02/2004
10Neoadjuvant Therapy
10/2020 - 05/2007
8Lymph Node Excision (Lymph Node Dissection)
08/2011 - 08/2003
6Radiotherapy
03/2022 - 11/2016
6Adjuvant Chemotherapy
01/2022 - 01/2006
6Lasers (Laser)
10/2011 - 01/2005
4Segmental Mastectomy (Lumpectomy)
03/2022 - 07/2013
4Hysterectomy
12/2019 - 08/2003
3Photochemotherapy (Photodynamic Therapy)
10/2020 - 10/2016
3Radiofrequency Ablation
08/2016 - 05/2009
3Prostatectomy (Retropubic Prostatectomy)
03/2012 - 02/2010
2Salpingo-oophorectomy
09/2017 - 08/2013
2Prophylactic Mastectomy
09/2017 - 06/2005
2Computer-Assisted Surgery (Image Guided Surgery)
12/2016 - 07/2013
2Palliative Care (Palliative Therapy)
12/2015 - 01/2015